PTEN Loss Shapes Macrophage Dynamics in High-Grade Serous Ovarian Carcinoma.

Saved in:
Bibliographic Details
Title: PTEN Loss Shapes Macrophage Dynamics in High-Grade Serous Ovarian Carcinoma.
Authors: Spear S; Ovarian Cancer Action Research Centre, Department of Surgery & Cancer, Imperial College London; London, United Kingdom., Le Saux O; Ovarian Cancer Action Research Centre, Department of Surgery & Cancer, Imperial College London; London, United Kingdom.; Centre Léon Bérard, Department of Medical Oncology, Lyon, France., Mirza HB; Ovarian Cancer Action Research Centre, Department of Surgery & Cancer, Imperial College London; London, United Kingdom., Iyer N; Ovarian Cancer Action Research Centre, Department of Surgery & Cancer, Imperial College London; London, United Kingdom., Tyson K; Ovarian Cancer Action Research Centre, Department of Surgery & Cancer, Imperial College London; London, United Kingdom., Grundland Freile F; Ovarian Cancer Action Research Centre, Department of Surgery & Cancer, Imperial College London; London, United Kingdom., Walton JB; Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.; Centre for Cancer and Inflammation, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Woodman C; Ovarian Cancer Action Research Centre, Department of Surgery & Cancer, Imperial College London; London, United Kingdom., Jarvis S; Department of Surgery & Cancer, Imperial College London, London, United Kingdom., Ennis DP; Ovarian Cancer Action Research Centre, Department of Surgery & Cancer, Imperial College London; London, United Kingdom., Aguirre Hernandez C; Ovarian Cancer Action Research Centre, Department of Surgery & Cancer, Imperial College London; London, United Kingdom., Xu Y; Ovarian Cancer Action Research Centre, Department of Surgery & Cancer, Imperial College London; London, United Kingdom., Spiliopoulou P; Ovarian Cancer Action Research Centre, Department of Surgery & Cancer, Imperial College London; London, United Kingdom.; Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Brenton JD; CRUK Cambridge Institute, University of Cambridge, United Kingdom., Costa-Pereira AP; Ovarian Cancer Action Research Centre, Department of Surgery & Cancer, Imperial College London; London, United Kingdom., Cook DP; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Canada., Vanderhyden BC; Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Canada., Keun HC; Ovarian Cancer Action Research Centre, Department of Surgery & Cancer, Imperial College London; London, United Kingdom., Triantafyllou E; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom., Arnold JN; School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom., McNeish IA; Ovarian Cancer Action Research Centre, Department of Surgery & Cancer, Imperial College London; London, United Kingdom.
Source: Cancer research [Cancer Res] 2024 Nov 15; Vol. 84 (22), pp. 3772-3787.
Publication Type: Journal Article
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1538-7445
DOI:10.1158/0008-5472.CAN-23-3890